Perrigo CEO Joseph Papa Stepping Down to Join Rival Valeant

Resignation plus profit downgrade of the U.S. drug maker traded on the Tel Aviv Stock Exchange sends shares tumbling in New York.

comments Print
The American drug maker traded on the Tel Aviv Stock Exchange, said Monday its long-serving CEO Joseph Papa was leaving to take the top job at rival Valeant. The company also downgraded forecasts for 2016...